Few studies have examined in vivo virulence gene expression in Streptococcus pneumoniae. In this study, expression of key pneumococcal virulence genes cbpA, pspA, ply, psaA, cps2A, piaA, nanA and spxB in the nasopharynx, lungs and bloodstream of mice was investigated, following intranasal challenge with the serotype 2 strain D39. Bacterial RNA was extracted, linearly amplified and assayed by real-time RT-PCR. At 72 h, cbpA mRNA was present at higher levels in the nasopharynx and lungs than in the blood. At this time-point, the mRNAs for PspA and PiaA were most abundant in the nasopharynx, whereas no significant difference in gene expression between niches was observed for ply, psaA and cps2A. Both nanA and spxB mRNAs were present in higher amounts in the nasopharynx than in the lungs or blood. These findings illustrate the dynamic nature of pneumococcal virulence gene expression in vivo.
INTRODUCTIONStreptococcus pneumoniae (the pneumococcus) is a globally significant pathogen, responsible for invasive diseases such as pneumonia, bacteraemia and meningitis . The pneumococcus asymptomatically colonizes the nasopharynx, and such carriage is considered essential for subsequent development of disease in susceptible individuals (particularly infants, the elderly, and the immunocompromised). Disease commonly occurs following the aspiration of bacteria from the nasopharynx into the lungs, followed by colonization of the pulmonary epithelium and subsequent development of pneumonia. From this niche, the pneumococcus can invade the bloodstream and cause sepsis. Alternatively, bacteraemia can occur, following direct translocation from the nasopharyngeal epithelium into underlying tissues. The gene regulatory mechanisms involved in transition between, and survival in, these distinct host niches are poorly understood. This has primarily been due to technical difficulties in harvesting sufficient quantities of pneumococci from an animal model to perform accurate and quantitative RNA assays, particularly from niches such as the nasopharynx, in which bacteria exist asymptomatically and in low numbers.Several studies have been conducted in recent years comparing in vivo and in vitro pneumococcal gene expression. Orihuela et al. (2000) used Northern blotting to assess virulence gene mRNA levels in type 3 pneumococci grown in sealed dialysis bags implanted in the murine peritoneal cavity. In another study, differences in gene expression between virulent type 2 pneumococci harvested from the blood of mice infected intraperitoneally and those grown in serum broth were examined using semi-quantitative RT-PCR (Ogunniyi et al., 2002). More recently, in vivo studies have used microarray technology to quantitate S. pneumoniae transcript abundance in the blood of infected mice and the cerebrospinal fluid of infected rabbits (Orihuela et al., 2004b).The present work is the first to evaluate in vivo changes in pneumococcal gene expression during the natural progression of disease from colonization of the nasopharynx to invasion of the lungs...